Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066387
Filing Date
2025-05-08
Accepted
2025-05-08 07:25:20
Documents
75
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnmd-20250331.htm   iXBRL 10-Q 1669228
2 EX-10.1 mnmd-ex10_1.htm EX-10.1 88227
3 EX-10.2 mnmd-ex10_2.htm EX-10.2 87162
4 EX-10.3 mnmd-ex10_3.htm EX-10.3 94771
5 EX-10.4 mnmd-ex10_4.htm EX-10.4 27002
6 EX-10.5 mnmd-ex10_5.htm EX-10.5 283262
7 EX-31.1 mnmd-ex31_1.htm EX-31.1 17112
8 EX-31.2 mnmd-ex31_2.htm EX-31.2 18497
9 EX-32.1 mnmd-ex32_1.htm EX-32.1 9141
10 EX-32.2 mnmd-ex32_2.htm EX-32.2 10548
11 GRAPHIC img196101975_0.jpg GRAPHIC 661259
  Complete submission text file 0000950170-25-066387.txt   10132366

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnmd-20250331.xsd EX-101.SCH 1312479
77 EXTRACTED XBRL INSTANCE DOCUMENT mnmd-20250331_htm.xml XML 1392457
Mailing Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER SUITE 8500 NEW YORK NY 10007 212-220-6633
Mind Medicine (MindMed) Inc. (Filer) CIK: 0001813814 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40360 | Film No.: 25923866
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)